Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities.

Biritwum NK, Frempong KK, Verver S, Odoom S, Alomatu B, Asiedu O, Kontoroupis P, Yeboah A, Hervie ET, Marfo B, Boakye DA, de Vlas SJ, Gyapong JO, Stolk WA.

PLoS Negl Trop Dis. 2019 Aug 9;13(8):e0007115. doi: 10.1371/journal.pntd.0007115. [Epub ahead of print]

2.

The Incidence of Non-Tuberculous Mycobacteria in Infants in Kenya.

Kaguthi G, Nduba V, Murithi W, Verver S.

J Trop Med. 2019 Jul 3;2019:1273235. doi: 10.1155/2019/1273235. eCollection 2019.

3.

Predictors of post neonatal mortality in Western Kenya: a cohort study.

Kaguthi G, Nduba V, Borgdorff MW, Verver S.

Pan Afr Med J. 2018 Oct 15;31:114. doi: 10.11604/pamj.2018.31.114.16725. eCollection 2018.

4.

Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area.

Rosales-Klintz S, Bruchfeld J, Haas W, Heldal E, Houben RMGJ, van Kessel F, Mandelbaum M, Matteelli A, Migliori GB, Oordt-Speets A, Solovic I, Vašáková M, Verver S, de Vlas SJ, Vonk Noordegraaf-Schouten MJM, de Vries G, Zenner D, van der Werf MJ.

Eur Respir J. 2019 Jan 17;53(1). pii: 1802077. doi: 10.1183/13993003.02077-2018. Print 2019 Jan. No abstract available.

PMID:
30655449
5.

The use of augmented toys to facilitate play in school-aged children with visual impairments.

Verver SH, Vervloed MPJ, Steenbergen B.

Res Dev Disabil. 2019 Feb;85:70-81. doi: 10.1016/j.ridd.2018.11.006. Epub 2018 Nov 24.

PMID:
30481675
6.

How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.

Verver S, Walker M, Kim YE, Fobi G, Tekle AH, Zouré HGM, Wanji S, Boakye DA, Kuesel AC, de Vlas SJ, Boussinesq M, Basáñez MG, Stolk WA.

Clin Infect Dis. 2018 Jun 1;66(suppl_4):S267-S274. doi: 10.1093/cid/cix1137.

7.

Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania.

Said K, Verver S, Kalingonji A, Lwilla F, Mkopi A, Charalambous S, Reither K.

Afr Health Sci. 2017 Mar;17(1):208-215. doi: 10.4314/ahs.v17i1.26.

8.

Method Modification for the Atlas Listeria Environmental LE Detection Assay Using FoodChek Actero Listeria Enrichment Media and Half-Fraser Media for the Detection of Listeria spp. from Environmental Surfaces.

Maroni B, Lopez T, Neal C, Verver S, Puente C, Lauffer J, Garcia J, Groschel B, Dreyling E, Chaney WE, Bastin B, Bird P, Benzinger MJ, Agin J, Goins D, Hariram U, Chen Y, Ryser E, Brodsky M.

J AOAC Int. 2018 Mar 1;101(2):562-576. doi: 10.5740/jaoacint.17-0273. Epub 2017 Aug 31.

PMID:
28859699
9.

Risk factors associated with loss to follow-up from tuberculosis treatment in Tajikistan: a case-control study.

Wohlleben J, Makhmudova M, Saidova F, Azamova S, Mergenthaler C, Verver S.

BMC Infect Dis. 2017 Aug 4;17(1):543. doi: 10.1186/s12879-017-2655-7.

10.

Feasibility of district wide screening of health care workers for tuberculosis in Zambia.

Verver S, Kapata N, Simpungwe MK, Kaminsa S, Mwale M, Mukwangole C, Sichinga B, Ahmedov S, Meis M.

BMC Public Health. 2017 Jul 14;18(1):17. doi: 10.1186/s12889-017-4578-z. Erratum in: BMC Public Health. 2017 Sep 22;17 (1):736.

11.

Infection control and tuberculosis among health care workers in Viet Nam, 2009-2013: a cross-sectional survey.

Tiemersma EW, Huong NT, Yen PH, Tinh BT, Thuy TT, Van Hung N, Mai NT, Verver S, Gebhard A, Nhung NV.

BMC Infect Dis. 2016 Nov 10;16(1):664.

12.

The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy.

Kufa T, Chihota V, Mngomezulu V, Charalambous S, Verver S, Churchyard G, Borgdorff M.

BMC Infect Dis. 2016 Jun 10;16:266. doi: 10.1186/s12879-016-1598-8.

13.

A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD, Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes EJ, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH, Thiel B, Ottenhoff THM, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SHE, Walzl G, Aderem A, Hanekom WA; ACS and GC6-74 cohort study groups.

Lancet. 2016 Jun 4;387(10035):2312-2322. doi: 10.1016/S0140-6736(15)01316-1. Epub 2016 Mar 24.

14.

Prevalence and risk factors of latent Tuberculosis among adolescents in rural Eastern Uganda.

Mumpe-Mwanja D, Verver S, Yeka A, Etwom A, Waako J, Ssengooba W, Matovu JK, Wanyenze RK, Musoke P, Mayanja-Kizza H.

Afr Health Sci. 2015 Sep;15(3):851-60. doi: 10.4314/ahs.v15i3.20.

15.

Two year mortality and associated factors in a cohort of children from rural Uganda.

Nabongo P, Verver S, Nangobi E, Mutunzi R, Wajja A, Mayanja-Kizza H, Kadobera D, Galiwango E, Colebunders R, Musoke P.

BMC Public Health. 2014 Apr 5;14:314. doi: 10.1186/1471-2458-14-314.

16.

Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.

Erkens CG, Dinmohamed AG, Kamphorst M, Toumanian S, van Nispen-Dobrescu R, Alink M, Oudshoorn N, Mensen M, van den Hof S, Borgdorff M, Verver S.

Int J Tuberc Lung Dis. 2014 Apr;18(4):413-20. doi: 10.5588/ijtld.13.0589.

PMID:
24670695
17.

Improved services to enrollees into an HIV rural care and treatment center in Tanzania.

Said K, Mkopi A, Verver S, Lwilla F, Churchyard G, Shekalaghe S, Battegay M, Reither K.

Pan Afr Med J. 2013 Sep 30;16:34. doi: 10.11604/pamj.2013.16.34.1642. eCollection 2013.

18.

The tuberculin skin test in school going adolescents in South India: associations of socio-demographic and clinical characteristics with TST positivity and non-response.

Uppada DR, Selvam S, Jesuraj N, Bennett S, Verver S, Grewal HM, Vaz M; TB Trials Study Group.

BMC Infect Dis. 2014 Nov 18;14:571. doi: 10.1186/s12879-014-0571-7.

19.

Implementation of tuberculosis infection control in health facilities in Mukono and Wakiso districts, Uganda.

Buregyeya E, Nuwaha F, Verver S, Criel B, Colebunders R, Wanyenze R, Kalyango JN, Katamba A, Mitchell EM.

BMC Infect Dis. 2013 Aug 1;13:360. doi: 10.1186/1471-2334-13-360.

20.

Burden of tuberculosis disease among adolescents in a rural cohort in Eastern Uganda.

Waako J, Verver S, Wajja A, Ssengooba W, Joloba ML, Colebunders R, Musoke P, Mayanja-Kizza H.

BMC Infect Dis. 2013 Jul 26;13:349. doi: 10.1186/1471-2334-13-349.

21.

Reply: Risk of tuberculosis among QuantiFERON converters and nonconverters.

Mahomed H, Machingaidze S, Hanekom WA, Hatherill M, Verver S.

Am J Respir Crit Care Med. 2013 May 15;187(10):1140-1. doi: 10.1164/rccm.201301-0160LE. No abstract available.

PMID:
23675721
22.

TB incidence in an adolescent cohort in South Africa.

Mahomed H, Ehrlich R, Hawkridge T, Hatherill M, Geiter L, Kafaar F, Abrahams DA, Mulenga H, Tameris M, Geldenhuys H, Hanekom WA, Verver S, Hussey GD.

PLoS One. 2013;8(3):e59652. doi: 10.1371/journal.pone.0059652. Epub 2013 Mar 22.

23.

Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adults.

Kufa T, Chihota V, Charalambous S, Verver S, Churchyard G.

Public Health Action. 2013 Mar 21;3(1):31-7. doi: 10.5588/pha.12.0102.

24.

Screening for TB in high school adolescents in a high burden setting in South Africa.

Mahomed H, Ehrlich R, Hawkridge T, Hatherill M, Geiter L, Kafaar F, Abrahams DA, Mulenga H, Tameris M, Geldenhuys H, Hanekom WA, Verver S, Hussey GD.

Tuberculosis (Edinb). 2013 May;93(3):357-62. doi: 10.1016/j.tube.2013.02.007. Epub 2013 Mar 7.

PMID:
23477938
25.

An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda.

Ssengooba W, Kateete DP, Wajja A, Bugumirwa E, Mboowa G, Namaganda C, Nakayita G, Nassolo M, Mumbowa F, Asiimwe BB, Waako J, Verver S, Musoke P, Mayanja-Kizza H, Joloba ML.

Tuberc Res Treat. 2012;2012:970203. doi: 10.1155/2012/970203. Epub 2012 Dec 4.

26.

Utilization of HIV and tuberculosis services by health care workers in Uganda: implications for occupational health policies and implementation.

Buregyeya E, Nuwaha F, Wanyenze RK, Mitchell EM, Criel B, Verver S, Kasasa S, Colebunders R.

PLoS One. 2012;7(10):e46069. doi: 10.1371/journal.pone.0046069. Epub 2012 Oct 11.

27.

High yield of culture-based diagnosis in a TB-endemic setting.

Demers AM, Verver S, Boulle A, Warren R, van Helden P, Behr MA, Coetzee D.

BMC Infect Dis. 2012 Sep 14;12:218. doi: 10.1186/1471-2334-12-218.

28.

Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents.

Machingaidze S, Verver S, Mulenga H, Abrahams DA, Hatherill M, Hanekom W, Hussey GD, Mahomed H.

Am J Respir Crit Care Med. 2012 Nov 15;186(10):1051-6. doi: 10.1164/rccm.201206-1134OC. Epub 2012 Sep 6.

PMID:
22955316
29.

Tuberculosis treatment outcome monitoring in European Union countries: systematic review.

van Hest R, Ködmön C, Verver S, Erkens CG, Straetemans M, Manissero D, de Vries G.

Eur Respir J. 2013 Mar;41(3):635-43. doi: 10.1183/09031936.00030612. Epub 2012 Jul 12. Review.

30.

Tuberculosis case finding for vaccine trials in young children in high-incidence settings: a randomised trial.

Moyo S, Verver S, Hawkridge A, Geiter L, Hatherill M, Workman L, Ontong C, Msemburi W, Tameris M, Geldenhuys H, Mulenga H, Snowden MA, Hanekom WA, Hussey G, Mahomed H; South African Tuberculosis Vaccine Initiative Neonatal Study Team.

Int J Tuberc Lung Dis. 2012 Feb;16(2):185-91. doi: 10.5588/ijtld.11.0348.

PMID:
22236918
31.

Consensus statement on diagnostic end points for infant tuberculosis vaccine trials.

Hatherill M, Verver S, Mahomed H; Taskforce on Clinical Research Issues, Stop TB Partnership Working Group on TB Vaccines.

Clin Infect Dis. 2012 Feb 15;54(4):493-501. doi: 10.1093/cid/cir823. Epub 2011 Dec 5.

PMID:
22144538
32.

Tuberculin skin test and QuantiFERON® assay in young children investigated for tuberculosis in South Africa.

Moyo S, Isaacs F, Gelderbloem S, Verver S, Hawkridge AJ, Hatherill M, Tameris M, Geldenhuys H, Workman L, Pai M, Hussey G, Hanekom WA, Mahomed H.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1176-81, i. doi: 10.5588/ijtld.10.0770.

PMID:
21943841
33.

Capture-recapture to estimate completeness of tuberculosis surveillance in two communities in South Africa.

Dunbar R, van Hest R, Lawrence K, Verver S, Enarson DA, Lombard C, Beyers N, Barnes JM.

Int J Tuberc Lung Dis. 2011 Aug;15(8):1038-43. doi: 10.5588/ijtld.10.0695.

PMID:
21740665
34.

Phenotypic variability in childhood TB: implications for diagnostic endpoints in tuberculosis vaccine trials.

Mulenga H, Moyo S, Workman L, Hawkridge T, Verver S, Tameris M, Geldenhuys H, Hanekom W, Mahomed H, Hussey G, Hatherill M.

Vaccine. 2011 Jun 10;29(26):4316-21. doi: 10.1016/j.vaccine.2011.04.020. Epub 2011 Apr 27.

PMID:
21527304
35.

The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa.

Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, Hatherill M, Ehrlich R, Hanekom WA, Hussey GD.

PLoS One. 2011 Mar 29;6(3):e17984. doi: 10.1371/journal.pone.0017984. Erratum in: PLoS One. 2011;6(6). doi:10.1371/annotation/b371be66-de38-4ed6-b440-d27c9d7e552c.

36.

Accuracy and completeness of recording of confirmed tuberculosis in two South African communities.

Dunbar R, Lawrence K, Verver S, Enarson DA, Lombard C, Hargrove J, Caldwell J, Beyers N, Barnes JM.

Int J Tuberc Lung Dis. 2011 Mar;15(3):337-43.

PMID:
21333100
37.

Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa.

Mahomed H, Hawkridge T, Verver S, Geiter L, Hatherill M, Abrahams DA, Ehrlich R, Hanekom WA, Hussey GD; SATVI Adolescent Study Team.

Int J Tuberc Lung Dis. 2011 Mar;15(3):331-6.

PMID:
21333099
38.

Risk of travelling to the country of origin for tuberculosis among immigrants living in a low-incidence country.

Kik SV, Mensen M, Beltman M, Gijsberts M, van Ameijden EJ, Cobelens FG, Erkens C, Borgdorff MW, Verver S.

Int J Tuberc Lung Dis. 2011 Jan;15(1):38-43.

PMID:
21276294
39.

The tuberculin skin test: a comparison of ruler and calliper readings.

Geldenhuys H, Verver S, Surtie S, Hatherill M, van Leth F, Kafaar F, Tameris M, Kleynhans W, Luabeya KK, Moyo S, Sikhondze W, Hanekom W, Mahomed H.

Int J Tuberc Lung Dis. 2010 Oct;14(10):1266-71.

PMID:
20843417
40.

Use of simulated sputum specimens to estimate the specificity of laboratory-diagnosed tuberculosis.

Demers AM, Boulle A, Warren R, Verver S, van Helden P, Behr MA, Coetzee D.

Int J Tuberc Lung Dis. 2010 Aug;14(8):1016-23.

PMID:
20626947
41.

Age-related tuberculosis incidence and severity in children under 5 years of age in Cape Town, South Africa.

Moyo S, Verver S, Mahomed H, Hawkridge A, Kibel M, Hatherill M, Tameris M, Geldenhuys H, Hanekom W, Hussey G.

Int J Tuberc Lung Dis. 2010 Feb;14(2):149-54.

PMID:
20074404
42.

Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations.

Klinkenberg E, Manissero D, Semenza JC, Verver S.

Eur Respir J. 2009 Nov;34(5):1180-9. doi: 10.1183/09031936.00038009. Review.

43.

Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts.

Kik SV, Franken WP, Mensen M, Cobelens FG, Kamphorst M, Arend SM, Erkens C, Gebhard A, Borgdorff MW, Verver S.

Eur Respir J. 2010 Jun;35(6):1346-53. doi: 10.1183/09031936.00098509. Epub 2009 Oct 19.

44.

Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands.

Kik SV, Olthof SP, de Vries JT, Menzies D, Kincler N, van Loenhout-Rooyakkers J, Burdo C, Verver S.

BMC Public Health. 2009 Aug 5;9:283. doi: 10.1186/1471-2458-9-283.

45.

Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis.

Kik SV, Franken WP, Arend SM, Mensen M, Cobelens FG, Kamphorst M, van Dissel JT, Borgdorff MW, Verver S.

Int J Tuberc Lung Dis. 2009 Jul;13(7):820-8.

PMID:
19555530
46.

Primary and postprimary or reactivation tuberculosis: time to revise confusing terminology?

Marais BJ, Parker SK, Verver S, van Rie A, Warren RM.

AJR Am J Roentgenol. 2009 Apr;192(4):W198; author reply W199-200. doi: 10.2214/AJR.08.1726. No abstract available.

PMID:
19304682
47.

No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa.

Kritzinger FE, den Boon S, Verver S, Enarson DA, Lombard CJ, Borgdorff MW, Gie RP, Beyers N.

Trop Med Int Health. 2009 Feb;14(2):136-42. doi: 10.1111/j.1365-3156.2008.02213.x.

48.

Annual meeting of the Tuberculosis Surveillance and Research Unit, 2008.

Zellweger JP, Verver S, van den Hof S, Hesseling A, Williams B, van Leth F, Rieder HL, Borgdorff MW.

Int J Tuberc Lung Dis. 2009 Feb;13(2):177-80.

PMID:
19146744
49.

Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands.

Tostmann A, Kik SV, Kalisvaart NA, Sebek MM, Verver S, Boeree MJ, van Soolingen D.

Clin Infect Dis. 2008 Nov 1;47(9):1135-42. doi: 10.1086/591974.

PMID:
18823268
50.

From suspect to patient: tuberculosis diagnosis and treatment initiation in health facilities in South Africa.

Botha E, den Boon S, Lawrence KA, Reuter H, Verver S, Lombard CJ, Dye C, Enarson DA, Beyers N.

Int J Tuberc Lung Dis. 2008 Aug;12(8):936-41.

PMID:
18647454

Supplemental Content

Loading ...
Support Center